Role of anti-TNF-α therapy in fat graft preservation

Annals of Plastic Surgery

Volumn 68, Issue 5, 2012, Pages 531-535

  Yang, Mei ^a   Zhang, Feng ^a   Sailes, Frederick C ^a   Zhang, Elizabeth W ^a   Lin, Shuyin ^a   Das, Suman K ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b Das Plastic Surgery Center   (United States)

Author keywords

fat graft; gene expression; TNF

Indexed keywords

BIOLOGICAL MARKER; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; APOPTOSIS; ARTICLE; DRUG EFFECT; EVALUATION; IMMUNOLOGY; MALE; METABOLISM; METHODOLOGY; NICK END LABELING; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; SUBCUTANEOUS FAT; TISSUE TRANSPLANTATION; TRANSPLANTATION; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

ADIPOCYTES, WHITE; ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; BIOLOGICAL MARKERS; IMMUNOLOGIC FACTORS; IN SITU NICK-END LABELING; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; TISSUE TRANSPLANTATION; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 84860779325     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e31821deb1b     Document Type: Conference Paper

References (24)

1. Nguyen A, Pasyk KA, Bouvier TN, et al. Comparative study of survival of autologous adipose tissue taken and transplanted by different techniques. Plast Reconstr Surg. 1990;85:378-386.
2. Mikus JL, Koufman JA, Kilpatrick SE. Fate of liposuctioned and purified autologous fat injections in the canine vocal fold. Laryngoscope. 1995;105:17-22.
3. Bauer CA, Valentino J, Hoffmann HT. Long-term result of vocal cord augmentation with autogenous fat. Ann Otol Laryngol. 1995;104:871-875.
4. Zaretsky LS, Shido ML, DeTar M, et al. Autologous fat injection for vocal fold paralysis: Long-term histologic evaluation. Ann Otol Rhinol Laryngol. 1995;104:1-4.
5. Shindo ML, Zaretsky LS, Rice DH. Autologous fat injection for unilateral vocal fold paralysis. Ann Otol Rhinol Laryngol. 1996;105:602-660.
6. Billings E, May JW Jr. Historical review and present status of free fat graft autotransplantation in plastic and reconstructive surgery. Plast Reconstr Surg. 1989;83:368-381.
7. Nishimura T, Hashimoto H, Nakanishi I, et al. Microvascular angiogenesis and apoptosis in the survival of free fat grafts. Laryngoscope. 2000;110: 1333-1338.
8. Ramon Y, Shoshani O, Peled IJ, et al. Enhancing the take of injected adipose tissue by a simple method for concentrating fat cells. Plast Reconstr Surg. 2005;115:197-201.
9. Shoshani O, Berger J, Fodor L, et al. The effect of lidocaine and adrenaline on the viability of injected adipose tissue: An experimental study in nude mice. J Drugs Dermatol. 2005;4:311-316.
10. Duxue-Liang, Luo SJ, Hao XG, et al. The function of basic fibroblastic growth factor on revascularization of pearl fat graft transplantation. Zhonghua Zheng Xing Wai Ke Za Zhi. 2005;21:128-131.
11. Ben-Ari Z, Hochhauser E, Burstein I, et al. Role of anti-tumor necrosis factor-alpha in ischemia/reperfusion injury in isolated rat liver in a blood-free environment. Transplantation. 2002;73:1875-1880.
12. Ye Q, Wang Z, Li Y, et al. The effect of anti-TfR mouse/human chimeric antibody on anti-transplant rejection. Transpl Int. 2011;24:167-174.
13. Ishii D, Schenk AD, Baba S, et al. Role of TNFalpha in early chemokine production and leukocyte infiltration into heart allografts. Am J Transplant. 2010;10:59-68.
14. Dretzke J, Edlin R, Round J, et al. A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-) inhibitors, adalimumab and infliximab, for Crohn's disease. Health Technol Assess. 2011;15:1-244.
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-408.
16. Kojima H, Tanaka Y, Tanaka T, et al. Cell proliferation and apoptosis in human middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg. 1998; 124:261-264.
17. Yamaguchi M, Matsumoto F, Bujo H, et al. Revascularization determines volume retention and gene expression by fat grafts in mice. Exp Biol Med (Maywood). 2005;230:742-748.
18. Lu F, Li J, Gao J, et al. Improvement of the survival of human autologous fat transplantation by using VEGF-transfected adipose-derived stem cells. Plast Reconstr Surg. 2000;124:1437-1446.
19. Nakamura S, Ishihara M, Takikawa M, et al. Increased survival of free fat grafts and vascularization in rats with local delivery of fragmin/protamine microparticles containing FGF-2 (F/P MP-F). J Biomed Mater Res B Appl Biomater. 2011;96:234-241.
20. Pires Fraga MF, Nishio RT, Ishikawa RS, et al. Increased survival of free fat grafts with platelet-rich plasma in rabbits. J Plast Reconstr Aesthet Surg 2010;63:e818-e822.
21. Hong SJ, Lee JH, Hong SM, et al. Enhancing the viability of fat grafts using new transfer medium containing insulin and beta-fibroblast growth factor in autologous fat transplantation. J Plast Reconstr Aesthet Surg. 2010;63:1202-1208.
22. Zhong X, Yan W, He X, et al. Improved fat graft viability by delayed fat flap with ischaemic pretreatment. J Plast Reconstr Aesthet Surg. 2009;62: 526-531.
23. Zhu M, Zhou Z, Chen Y, et al. Supplementation of fat grafts with adiposederived regenerative cells improves long-term graft retention. Ann Plast Surg. 2010;64:222-228.
24. Huang R, Zhou Q, Veeraragoo P, et al. Notch2/Hes-1 pathway plays an important role in renal ischemia and reperfusion injury-associated inflammation and apoptosis and the -secretase inhibitor DAPT has a nephroprotective effect. Ren Fail. 2011;33:207-216.